PRESS RELEASE published on 01/15/2025 at 18:44, 1 year 1 month ago Inside Information / Information on annual revenues IntegraGen, an OncoDNA Group company, reports 27% revenue drop in 2024 due to SeqOIA services cessation. Cash position at €1.9m. Growth seen outside SeqOIA Cash Position Growth Prospects Revenue Drop SeqOIA IntegraGen
BRIEF published on 07/18/2024 at 18:49, 1 year 7 months ago IntegraGen : Chiffre d'affaires en hausse malgré la perte de SeqOIA Chiffre D'affaires Croissance Certification CLIA Génomique SeqOIA
BRIEF published on 07/18/2024 at 18:49, 1 year 7 months ago IntegraGen: Revenue up despite loss of SeqOIA Growth Turnover CLIA Certification SeqOIA Genomic
PRESS RELEASE published on 07/18/2024 at 18:44, 1 year 7 months ago Informations privilégiées / Autres communiqués IntegraGen annonce un chiffre d'affaires de 4,5 M€ au premier semestre 2024, en hausse de 6%, avec une trésorerie de 2,8 M€. Perspectives de croissance et stratégie de réduction des coûts Chiffre D'affaires Croissance Trésorerie Certification CLIA IntegraGen
Published on 02/20/2026 at 18:30, 1 hour 42 minutes ago Sparta Updates Delay in Filing Annual Financial Statements
Published on 02/20/2026 at 15:45, 4 hours 27 minutes ago Revolve Announces Closing of Initial US$10 Million Advance on Strategic Financing With Callaway
Published on 02/20/2026 at 14:30, 5 hours 42 minutes ago Norse Gold Announces Application for Reactivation to TSX-V, Private Placement Financing and Stock Options Grant
Published on 02/20/2026 at 14:08, 6 hours 4 minutes ago Datavault AI Announces Anticipated Launch of Josh Gibson Stablecoin and Josh Gibson NIL Strategies for Its Forthcoming NIL Exchange
Published on 02/20/2026 at 14:00, 6 hours 12 minutes ago Nextech3D.ai's Eventdex Platform Powers AI Matchmaking for the SBA's CT Business Matchmaker Event Featuring Government Agencies and Major Prime Contractors
Published on 02/20/2026 at 18:36, 1 hour 35 minutes ago EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 18:31, 1 hour 41 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/20/2026 at 18:00, 2 hours 12 minutes ago Leclanché conclut un accord de financement d’un montant de CHF 16,7 millions pour soutenir ses opérations à court terme
Published on 02/20/2026 at 18:00, 2 hours 12 minutes ago Leclanché Secures Financing Arrangement in the amount of CHF 16.7 million to Support Near-Term Operations
Published on 02/20/2026 at 18:00, 2 hours 12 minutes ago TERACT - Résiliation du contrat de liquidité
